ResearcherJohns Hopkins UniversityNo recent work listed
Victoria Kim
Matched on ORCID iD 0000-0001-9451-4288; OpenAlex author ID A5048400388, A5101887847. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 40
2015: 1 paper · 2016: 1 paper · 2017: 1 paper · 2018: none · 2019: 2 papers · 2020: none · 2021: 1 paper
Papers 6
- Vaccine-Induced Intratumoral Lymphoid Aggregates Correlate with Survival Following Treatment with a Neoadjuvant and Adjuvant Vaccine in Patients with Resectabl… Co-author DOI 10.1158/1078-0432.ccr-20-2974↗
- Dissecting the Stromal Signaling and Regulation of Myeloid Cells and Memory Effector T Cells in Pancreatic Cancer. First author DOI 10.1158/1078-0432.ccr-18-4192↗
- IDO1 inhibition potentiates vaccine-induced immunity against pancreatic adenocarcinoma. Co-author DOI 10.1172/jci124077↗
- Long-term survival benefit of upfront chemotherapy in patients with newly diagnosed borderline resectable pancreatic cancer. Co-author DOI 10.1002/cam4.1104↗
- Current progress in immunotherapy for pancreatic cancer. First author DOI 10.1016/j.canlet.2015.12.020↗
- Early detection of pancreatic cancer. Co-author DOI 10.3978/j.issn.1000-9604.2015.07.03↗
Closest collaborators
The 25 strongest of 40 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Lei Zheng · 5 shared papers, 2016–2021 · strength 0.40
- Paper IDO1 inhibition potentiates vaccine-induced immunity against pancreatic adenocarcinoma. DOI 10.1172/jci124077↗
- Paper Current progress in immunotherapy for pancreatic cancer. DOI 10.1016/j.canlet.2015.12.020↗
- Paper Vaccine-Induced Intratumoral Lymphoid Aggregates Correlate with Survival Following Treatment with a Neoadjuvant and Adj… DOI 10.1158/1078-0432.ccr-20-2974↗
- Alex B. Blair · 4 shared papers, 2017–2021 · strength 0.32
- Paper IDO1 inhibition potentiates vaccine-induced immunity against pancreatic adenocarcinoma. DOI 10.1172/jci124077↗
- Paper Vaccine-Induced Intratumoral Lymphoid Aggregates Correlate with Survival Following Treatment with a Neoadjuvant and Adj… DOI 10.1158/1078-0432.ccr-20-2974↗
- Paper Dissecting the Stromal Signaling and Regulation of Myeloid Cells and Memory Effector T Cells in Pancreatic Cancer. DOI 10.1158/1078-0432.ccr-18-4192↗
- Elizabeth M. Jaffee · 3 shared papers, 2016–2021 · strength 0.25
- Paper Current progress in immunotherapy for pancreatic cancer. DOI 10.1016/j.canlet.2015.12.020↗
- Paper Vaccine-Induced Intratumoral Lymphoid Aggregates Correlate with Survival Following Treatment with a Neoadjuvant and Adj… DOI 10.1158/1078-0432.ccr-20-2974↗
- Paper Dissecting the Stromal Signaling and Regulation of Myeloid Cells and Memory Effector T Cells in Pancreatic Cancer. DOI 10.1158/1078-0432.ccr-18-4192↗
- Jin Peng He · 3 shared papers, 2017–2021 · strength 0.21
- Paper Vaccine-Induced Intratumoral Lymphoid Aggregates Correlate with Survival Following Treatment with a Neoadjuvant and Adj… DOI 10.1158/1078-0432.ccr-20-2974↗
- Paper Dissecting the Stromal Signaling and Regulation of Myeloid Cells and Memory Effector T Cells in Pancreatic Cancer. DOI 10.1158/1078-0432.ccr-18-4192↗
- Paper Long-term survival benefit of upfront chemotherapy in patients with newly diagnosed borderline resectable pancreatic ca… DOI 10.1002/cam4.1104↗
- Stephen T. Muth · 2 shared papers, 2019 · strength 0.19
- Christopher L. Wolfgang · 2 shared papers, 2019–2021 · strength 0.17
- Paper Vaccine-Induced Intratumoral Lymphoid Aggregates Correlate with Survival Following Treatment with a Neoadjuvant and Adj… DOI 10.1158/1078-0432.ccr-20-2974↗
- Paper Dissecting the Stromal Signaling and Regulation of Myeloid Cells and Memory Effector T Cells in Pancreatic Cancer. DOI 10.1158/1078-0432.ccr-18-4192↗
- Adrian Gerard Murphy · 2 shared papers, 2017–2019 · strength 0.15
- Nita Ahuja · 2 shared papers, 2015–2017 · strength 0.15
- Dung Thi Le · 2 shared papers, 2017–2021 · strength 0.13
- Paper Vaccine-Induced Intratumoral Lymphoid Aggregates Correlate with Survival Following Treatment with a Neoadjuvant and Adj… DOI 10.1158/1078-0432.ccr-20-2974↗
- Paper Long-term survival benefit of upfront chemotherapy in patients with newly diagnosed borderline resectable pancreatic ca… DOI 10.1002/cam4.1104↗
- Kevin C. Soares · 2 shared papers, 2017–2021 · strength 0.13
- Paper Vaccine-Induced Intratumoral Lymphoid Aggregates Correlate with Survival Following Treatment with a Neoadjuvant and Adj… DOI 10.1158/1078-0432.ccr-20-2974↗
- Paper Long-term survival benefit of upfront chemotherapy in patients with newly diagnosed borderline resectable pancreatic ca… DOI 10.1002/cam4.1104↗
- Ana De Jesus‐Acosta · 2 shared papers, 2017–2021 · strength 0.13
- Paper Vaccine-Induced Intratumoral Lymphoid Aggregates Correlate with Survival Following Treatment with a Neoadjuvant and Adj… DOI 10.1158/1078-0432.ccr-20-2974↗
- Paper Long-term survival benefit of upfront chemotherapy in patients with newly diagnosed borderline resectable pancreatic ca… DOI 10.1002/cam4.1104↗
- Amy Hacker‐Prietz · 2 shared papers, 2017–2021 · strength 0.13
- Paper Vaccine-Induced Intratumoral Lymphoid Aggregates Correlate with Survival Following Treatment with a Neoadjuvant and Adj… DOI 10.1158/1078-0432.ccr-20-2974↗
- Paper Long-term survival benefit of upfront chemotherapy in patients with newly diagnosed borderline resectable pancreatic ca… DOI 10.1002/cam4.1104↗
- Joseph M. Herman · 2 shared papers, 2017–2021 · strength 0.13
- Paper Vaccine-Induced Intratumoral Lymphoid Aggregates Correlate with Survival Following Treatment with a Neoadjuvant and Adj… DOI 10.1158/1078-0432.ccr-20-2974↗
- Paper Long-term survival benefit of upfront chemotherapy in patients with newly diagnosed borderline resectable pancreatic ca… DOI 10.1002/cam4.1104↗
- Nilofer Saba Azad · 2 shared papers, 2017–2021 · strength 0.13
- Paper Vaccine-Induced Intratumoral Lymphoid Aggregates Correlate with Survival Following Treatment with a Neoadjuvant and Adj… DOI 10.1158/1078-0432.ccr-20-2974↗
- Paper Long-term survival benefit of upfront chemotherapy in patients with newly diagnosed borderline resectable pancreatic ca… DOI 10.1002/cam4.1104↗
- Martin A. Makary · 2 shared papers, 2017–2021 · strength 0.13
- Paper Vaccine-Induced Intratumoral Lymphoid Aggregates Correlate with Survival Following Treatment with a Neoadjuvant and Adj… DOI 10.1158/1078-0432.ccr-20-2974↗
- Paper Long-term survival benefit of upfront chemotherapy in patients with newly diagnosed borderline resectable pancreatic ca… DOI 10.1002/cam4.1104↗
- Matthew John Weiss · 2 shared papers, 2017–2021 · strength 0.13
- Paper Vaccine-Induced Intratumoral Lymphoid Aggregates Correlate with Survival Following Treatment with a Neoadjuvant and Adj… DOI 10.1158/1078-0432.ccr-20-2974↗
- Paper Long-term survival benefit of upfront chemotherapy in patients with newly diagnosed borderline resectable pancreatic ca… DOI 10.1002/cam4.1104↗
- Daniel A. Laheru · 2 shared papers, 2017–2021 · strength 0.13
- Paper Vaccine-Induced Intratumoral Lymphoid Aggregates Correlate with Survival Following Treatment with a Neoadjuvant and Adj… DOI 10.1158/1078-0432.ccr-20-2974↗
- Paper Long-term survival benefit of upfront chemotherapy in patients with newly diagnosed borderline resectable pancreatic ca… DOI 10.1002/cam4.1104↗
- Kelly Foley · 1 shared paper, 2016 · strength 0.08
- Robert A. Anders · 1 shared paper, 2021 · strength 0.08
- Ding Ding · 1 shared paper, 2021 · strength 0.08
- Barish H. Edil · 1 shared paper, 2021 · strength 0.08
- Arsen Osipov · 1 shared paper, 2021 · strength 0.08
- Richard David Schulick · 1 shared paper, 2021 · strength 0.08
- Katherine M. Bever · 1 shared paper, 2021 · strength 0.08
- Lisa M. Coussens · 1 shared paper, 2019 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.